Skip to main content

Table 4 Any symptoms ever likely related to Fabry disease of 44 women

From: Pregnancy outcomes of Fabry disease in Austria (PROFABIA)-a retrospective cohort-study

 

All women (n = 44)

With pregnancy (n = 32)

Without pregnancy (n = 12)

Women with symptoms

38 (86.4)

28 (87.5)

10 (83.4)

Women without symptomsa

6 (13.7)

4 (12.5)

2 (16.7)

Age at study entry

44 (30, 51)

48 (39, 54)

24 (21, 32)

Hypohidrosis, cold or heat intolerance

21 (47.7)

15 (46.9)

6 (50.0)

Acroparesthesia

25 (56.8)

17 (53.1)

8 (66.7)

Pain

23 (52.3)

17 (53.1)

6 (50.0)

Angiokeratomas

8 (18.2)

6 (18.8)

2 (16.7)

Neurologic symptoms

10 (22.7)

9 (28.1)

1 (8.3)

Cerebrovascular event

3 (6.8)

2 (6.3)

1 (8.3)

Cardiac symptoms

15 (34.1)

14 (43.8)

1 (8.3)

Angina

8 (18.2)

8 (25.0)

0

Kidney disease

11 (25.0)

11 (34.4)

0

Proteinuria

15 (34.1)

12 (37.5)

3 (25.0)

Hypertension

12 (27.3)

12 (37.5)

0

Gastrointestinal symptoms

22 (50.0)

16 (50.0)

6 (50.0)

Asthma/COPD

11 (25.0)

11 (34.4)

0

Anxiety disorder

7 (15.9)

6 (18.8)

1 (8.3)

Depression

16 (36.4)

14 (43.8)

2 (16.7)

Hypacusis

9 (20.5)

8 (25.0)

1 (8.3)

Tinnitus

10 (22.7)

10 (31.3)

0

Vertigo

14 (31.8)

12 (37.5)

2 (16.7)

Cornea veticillata

8 (18.2)

5 (15.6)

3 (25.0)

Other

7 (15.9)

6 (18.8)

1 (8.3)

  1. Data are given as n (%) or median (p25, p75)
  2. COPD chronic obstructive pulmonary disease
  3. aIncluding one index case with asymptomatic Fabry cardiomyopathy and five women identified by family screening